Clinical Trial

Desloratadine in Patients With Ulcerative Colitis

Study acronym: UC
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate safety and therapeutic efficacy of antihistamine (desloratadine) on inflammation and disease activity when administered as adjuvant therapies with the traditional therapy 5-aminosalisylic acid (mesalamine) in patients with mild to moderate ulcerative colitis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-01.
Status change: Not Yet Recruiting → Recruiting 2026-01-27
Trial Details
NCT Number NCT07333716
Lead Sponsor Tanta University
Conditions Ulcerative Colitis (UC), Ulcerative Colitis
Enrollment 44 participants
Start Date 2026-01-26
Primary Completion 2027-02 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-01-29